Speakers: 

Autumn Fogle, PharmD., PGY2 CCM Pharmacy Resident, Geisinger Medical Center - has nothing to disclose. 

 

Moderator: 

Sarah F. Hale, PharmD., BCPPS; Director of Pharmacy, Geisinger Medical Center - has nothing to disclose.

 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Discuss the role of argatroban and eptifibatide in ischemic stroke
  • Describe the results of the MOST trial and how they relate to current practice.

 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD; Brain Simpkins, PharmD; Jessica Milheim, CPhT and Nichole Varela Gonzalez, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Session date: 
10/09/2024 - 12:30pm to 1:30pm EDT
Location: 
GMC Main 5 Conference Room & Virtual
United States
  • 1.00 ACPE
  • 1.00 ACPE Tech
  • 1.00 Participation Credit

Please login or register to take this course.